STATE OF WISCONSIN
CONTROLLED SUBSTANCES BOARD
---------------------------------------------------------------------------------------------------------------------
IN THE MATTER OF RULE-MAKING   :   AFFIRMATIVE ACTION
PROCEEDINGS BEFORE THE     :   ORDER OF THE
CONTROLLED SUBSTANCES BOARD   :   CONTROLLED SUBSTANCES BOARD
---------------------------------------------------------------------------------------------------------------------
FINDINGS
1. On February 27, 2014, the Department of Justice, Drug Enforcement Administration published its final rule in the Federal Register listing Alfaxalone into schedule IV of the federal Controlled Substances Act. The scheduling action is effective March 31, 2014.
2. The Controlled Substances Board did not receive an objection to similarly listing Alfaxalone as a schedule IV under ch. 961, Stats. within 30 days of the date of publication in the federal register of the final order listing Alfaxalone as a schedule IV controlled substance.
3. The Controlled Substances Board will promulgate a final rule, without making the determinations or findings required by ss. 961.11(1), (1m), (1r) and (2) or s. 961.19 and omitting the notice of proposed rule making, listing Alfaxalone as a schedule IV controlled substance.
ORDER
Pursuant to s. 961.11(4), Stats., the Controlled Substances Board by affirmative action similarly treats Alfaxalone under chapter 961, Stats. by renumbering and creating the following:
CSB 2.84 Addition of Alfaxalone to schedule IV. Section 961.20 (2) (a), Stat., is repealed and recreated to read:
961.20 (2) (a) Alfaxalone.
Section 961.20 (2) (ak) is created to read:
961.20 (2) (ak) Alprazolam
This order shall take effect upon publication in the Administrative Register. The order expires upon promulgation of a final rule.
Dated 7/9/2021           _______________________
              Doug Englebert, Chair
              Controlled Substances Board
Loading...
Loading...
Links to Admin. Code and Statutes in this Register are to current versions, which may not be the version that was referred to in the original published document.